DEAGE
Live / Allowed — Notice of allowance issued (as of 01 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 11 Feb 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 99647697
- Mark type
- Word mark
- Filed
- 11 Feb 2026
- Published for opposition
- 07 Jul 2026
- Attorney of record
- Andrew D. Bochner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses, degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease; Pharmaceutical preparations for the treatment of Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease, Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease; Medicinal preparations for the treatment of Sepsis, Septic Shock, bacterial skin and tissue Infections, fungal skin and tissue Infections, viral skin and tissue Infections, parasitic skin and tissue infections, Pneumonia, Acute Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Chronic Lung Disease of Prematurity, Osteoarthritis, osteoarthritis of the knee, osteoarthritis of the hip, osteoarthritis of the shoulder, other osteoarthroses; Medicinal preparations for degenerative disc disease, namely, intervertebral disc degeneration, Alzheimer’s disease, Parkinson’s disease, Neonatal Stroke, Neonatal Sepsis, Intraventricular Hemorrhage, Ischemic Stroke, Hemorrhagic Stroke, Perioperative Myocardial Infarction, heart failure, chronic kidney disease; Medicinal preparations for Chronic Obstructive Pulmonary Disease (COPD), idiopathic pulmonary fibrosis, diabetic foot ulcers, type 1 diabetes mellitus, Graft versus Host Disease (GvHD), rheumatoid arthritis, ankylosing spondylitis, multiple sclerosis, psoriasis, perianal fistulas associated with Crohn’s disease
Owner
- MDTB Cells GmbH, Radebeul, DE
- MDTB Cells GmbH, Radebeul, DE
Prosecution history
- 01 Sept 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Jul 2026 — PUBLISHED FOR OPPOSITION
- 01 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Jun 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Feb 2026 — NEW APPLICATION ENTERED